Moreover, microarray transcriptome data sets of alcoholic steatohepatitis (ASH)23 revealed that GDF15 expression was elevated in the liver of human ASH patients compared to control subjects (Fig. 1h), suggesting that GDF15 is a potential biomarker for a variety of steatohepatitis. This evidence concerns the gene GDF15 and alcoholic fatty liver disease.